Raj Yadav is a Scientist in Development Sciences of Research & Early Development organization at Genentech, South San Francisco, California, USA. His current work at Genentech focuses on leading the pharmacokinetics and pharmacodynamics (PKPD) efforts to guide the design, delivery, and development of biologics molecules (bispecifics, fusion proteins, and other novel antibody-based therapeutic modalities) in early-stage research to post-marketing. Raj holds a Ph.D. in translational PKPD, modeling and simulations from Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia. In addition, he obtained his M Pharm from NIPER, Mohali and B Pharm from UP technical University, Lucknow, India. In his previous role, he worked in nonclinical DMPK research to translational PK/PD M&S at BMS R & D Center, Bangalore. Raj is an author of more than 20 publications in prestigious journals covering antibodies, antibiotics, translational PKPD modeling and simulations, and optimization of clinical dosage regimens for critically-ill patients. He also serves as a reviewer of several reputed journals in the field and currently a member of scientific advisory board to the Journal of Pharmaceutical Sciences.